Congenital heart defect with associated malformations in children

Michał Wojtalik1, Wojciech Mrówczyński, Jacek Henschke

  • 1Department of Paediatric Cardiac Surgery, Karol Marcinkowski University of Medical Sciences, Poznan 60-572, Poland.

Insights

Congenital heart defects (CHD) with other system malformations in children increase mortality risk. Younger age, urgent procedures, and primary cardiac surgery negatively impact outcomes, though some interventions can stabilize patients.

Area of Science:

  • Pediatric Cardiology
  • Congenital Malformations
  • Surgical Outcomes

Background:

  • Multisystem involvement in children, including congenital heart defects (CHD), presents significant clinical challenges.
  • Evaluating the incidence and treatment of CHD with associated malformations is crucial for pediatric cardiac surgery patients.

Purpose of the Study:

  • To determine the incidence of CHD associated with malformations in other organ systems.
  • To assess treatment modalities and perioperative mortality in pediatric patients with complex CHD.

Main Methods:

  • Retrospective review of 1856 children's medical records from 1997 to 2002.
  • Investigation of connections between CHD and other lesions, with univariate and multivariate analyses.
  • Scrutiny of patient and perioperative variables influencing mortality risk.

Main Results:

  • 4.53% of children had CHD with associated malformations, most commonly affecting digestive, urinary, and nervous systems.
  • No direct relation was found between CHD and concomitant lesions.
  • Mortality (approx. 19%) was significantly influenced by patient age, primary cardiac procedure, and CHD type.

Conclusions:

  • Treatment for children with CHD and multiple associated lesions carries a higher mortality risk.
  • Younger age, urgent procedures, and primary surgical interventions negatively impact patient outcomes.
  • Preceding cardiac procedures can improve outcomes through circulatory stabilization if the patient's condition permits.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...